TOWARDS A DISEASE-FREE WORLD
Let’s work together to bring revolutionairy therapeutics to the patient
BIMINI Biotech is developing therapeutic strategies for major unmet medical needs. Our first development program targets the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases and ageing. We do this through an unique mode-of-action.
BIMINI Biotech is always open for collaborations to accelerate drug development. Please do not hesitate to contact us.